Kathleen N. Moore, MD
Associate Professor
The University of Oklahoma
800 NE 10th St
Suite 5050
Oklahoma City,
OK
USA
73104
Biographical Sketch: Kathleen Moore is assistant professor of gyn oncology at the university of oklahoma where she serves as associate fellowship director and associate director of phase I clinical trials. She holds the Mai Eager Anderson Chair in Cancer Clinical Trials and serves and GOG Co-PI for the University of Oklahoma.
Papers:
12 - Focused Plenary
Operative outcomes among a geriatric population of endometrial cancer patients: an ancillary data analysis of Gynecologic Oncology Group study LAP2
46 - Featured Poster
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced-stage serous ovarian or primary peritoneal cancer: a Gynecologic Oncology Group (GOG) study
76 - Focused Plenary
Complications and surgical staging of endometrial cancer with respect to obesity: a Gynecologic Oncology Group LAP2 ancillary data study
94 - Featured Poster
Impact of age on tolerance of chemoradiation and survival for patients with local regionally advanced cervical cancer: a pooled analysis of Gynecologic Oncology Group (GOG) phase III trials
120 - Featured Poster
The influence of obesity on disease characteristics and survival among patients with epithelial ovarian cancer
164 - Poster Session A
Adenocarcinoma indicates more favorable prognosis with cervix cancer
224 - Poster Session A
Characterization of primary platinum resistance in an era of biologic agents and novel chemotherapeutic design
240 - Poster Session A
Venous thromboembolism carries a particularly grave prognosis with epithelial ovarian cancer
251 - Poster Session A
Acquired platinum resistance among women with high-grade serous epithelial ovarian cancer
367 - Poster Session B
Analysis of patients referred to an academic gynecologic oncology clinic with an OVA1 test
426 - Poster Session B
The effect of age on completion of prescribed chemoradiation among patients with cervix cancer
431 - Poster Session B
Measurements of adiposity as predictive biomarkers for response to first-line bevacizumab-based chemotherapy in epithelial ovarian cancer (EOC)
437 - Poster Session B
The impact of obesity on pathologic features and survival with endometrial cancer: a Gynecologic Oncology Group (GOG) LAP2 ancillary data study
Moderator Introductions
Peri-Operative Considerations in the Elderly Patient with Ovarian Cancer
Lecturette: The TCGA Concept